Bacteriocin-producing Lactobacillus pentosus and the use thereof in food and pharmaceutical compositions
AssigneeProbiotical S.P.A.
InventorsGiovanni Mogna, Gian Paolo Strozzi, Luca Mogna
Life of this patent
Estimating the term…
Abstract
The present invention relates to a selected strain of Lactobacillus pentosus for use as a medication for the preventive or curative treatment of infections due to Gram-negative bacteria, preferably enterococci, coliforms and E. coli.
Claims10
A method for treating gastroenteritis in a subject in need thereof, the method comprising orally administering to the subject an effective amount of isolated bacterial strain Lactobacillus pentosus LPS 01, deposited on Nov. 14, 2008 with Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ) under Accession Number No. DSM 21980, such that said gastroenteritis is treated.
A method for treating gastroenteritis in a subject in need thereof, the method comprising orally administering to the subject a pharmaceutical composition comprising an effective amount of isolated bacterial strain Lactobacillus pentosus LPS 01, deposited on Nov. 14, 2008 with Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ) under Accession Number DSM 21980, such that said gastroenteritis is treated.
Dependencies are inferred from the claim text.